Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,998,422
  • Shares Outstanding, K 52,257
  • Annual Sales, $ 302,240 K
  • Annual Income, $ 57,280 K
  • 36-Month Beta 1.58
  • Price/Sales 5.41
  • Price/Cash Flow 26.04
  • Price/Book 4.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.27
  • Number of Estimates 6
  • High Estimate 0.31
  • Low Estimate 0.21
  • Prior Year 0.44
  • Growth Rate Est. (year over year) -38.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.25 +10.95%
on 01/28/19
39.39 -0.71%
on 02/15/19
+1.28 (+3.38%)
since 01/15/19
3-Month
30.05 +30.15%
on 12/24/18
49.25 -20.59%
on 12/03/18
-4.00 (-9.28%)
since 11/15/18
52-Week
30.05 +30.15%
on 12/24/18
61.25 -36.15%
on 06/29/18
-0.04 (-0.10%)
since 02/15/18

Most Recent Stories

More News
Supernus to Host Fourth Quarter and Full Year 2018 Earnings Conference Call

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that...

SUPN : 39.21 (+2.54%)
Supernus Pharmac Rises 3.44% on Heavy Volume: Watch For Potential Pullback

Supernus Pharmac (NASDAQ:SUPN) traded in a range yesterday that spanned from a low of $37.58 to a high of $38.88. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high...

SUPN : 39.21 (+2.54%)
Supernus Pharmac has the Best Relative Performance in the Pharmaceuticals Industry (SUPN , PRGO , TXMD , AERI , MYL )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

SUPN : 39.21 (+2.54%)
PRGO : 48.97 (+0.76%)
MYL vs. SUPN: Which Stock Is the Better Value Option?

MYL vs. SUPN: Which Stock Is the Better Value Option?

MYL : 31.74 (+0.70%)
SUPN : 39.21 (+2.54%)
Supernus to Present at the 2019 J.P. Morgan Healthcare Conference

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the...

JPM : 105.51 (+3.02%)
SUPN : 39.21 (+2.54%)
Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD

-- Met primary endpoint with robust statistical significance

SUPN : 39.21 (+2.54%)
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR(R) Label to Include Monotherapy

Supernus Pharmaceuticals, Inc. (NASADQ: SUPN) announced today that the United States Food and Drug Administration (FDA) has approved the Company's supplemental new drug application (sNDA) for Oxtellar...

SUPN : 39.21 (+2.54%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Supernus Pharmac (SUPN , ZGNX , ITCI , PFE , ZTS )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 13.73 (+0.81%)
SUPN : 39.21 (+2.54%)
ZGNX : 47.35 (+0.62%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 9.42 (+0.75%)
EPAY : 47.65 (+1.32%)
EXAS : 87.83 (-0.33%)
WYNN : 124.20 (+0.62%)
HMSY : 32.10 (+2.65%)
GLT : 13.99 (+3.02%)
MHK : 139.44 (+0.46%)
BBW : 5.00 (+0.40%)
CDW : 94.15 (+0.32%)
COUP : 95.18 (-0.04%)
QTWO : 66.23 (-0.93%)
DENN : 17.91 (+1.88%)
MYL : 31.74 (+0.70%)
DFRG : 8.44 (-0.71%)
GCAP : 7.05 (+3.37%)
FEYE : 17.33 (-1.25%)
MXIM : 55.85 (+0.11%)
POL : 32.51 (+1.63%)
AN : 39.29 (+2.64%)
TWO : 13.87 (+0.29%)
HUBG : 45.43 (+0.09%)
AR : 9.60 (+5.84%)
RE : 217.08 (+1.42%)
NNBR : 10.29 (-0.10%)
ARE : 134.60 (+0.53%)
CVI : 42.34 (+0.59%)
CERS : 6.42 (+2.72%)
NDAQ : 87.07 (-0.10%)
ELLI : 98.86 (+0.11%)
BLDR : 13.51 (-0.07%)
EGRX : 41.38 (+2.10%)
RGLD : 86.87 (-0.69%)
PRGO : 48.97 (+0.76%)
PENN : 24.75 (+1.10%)
NTAP : 63.98 (+0.50%)
IBM : 137.90 (+1.04%)
NTRI : 43.36 (+0.39%)
BANR : 60.24 (+2.36%)
CWT : 50.96 (+0.22%)
STAA : 36.02 (+2.42%)
ATHN : 134.99 (+0.01%)
CL : 66.27 (+1.25%)
TFSL : 16.91 (+1.14%)
UFPI : 32.04 (+0.41%)
SDRL : 8.52 (+2.65%)
GOV : 6.87 (-5.50%)
HQY : 76.72 (+1.24%)
IPGP : 154.76 (+3.48%)
MINI : 35.99 (-0.14%)
CMTL : 27.43 (+1.78%)
CHD : 64.51 (+0.25%)
GPI : 61.51 (+3.47%)
HRL : 43.15 (+0.23%)
RARE : 56.08 (+1.12%)
MLI : 32.26 (+0.84%)
GPS : 25.11 (+0.76%)
CHS : 5.70 (+3.45%)
RYAM : 13.97 (+1.60%)
PBI : 7.07 (+1.14%)
NUVA : 58.61 (+0.19%)
IMDZ : 1.43 (-2.05%)
CAMP : 14.53 (+2.32%)
NOC : 285.30 (+1.67%)
AEL : 32.60 (+4.45%)
EBIX : 58.33 (+0.55%)
DISCA : 29.30 (+1.84%)
GPOR : 7.98 (+3.50%)
BGS : 26.10 (+0.35%)
TECH : 190.74 (+1.16%)
PCH : 35.17 (+0.46%)
NOV : 29.62 (+2.03%)
TECD : 103.49 (+0.33%)
DISCK : 27.67 (+1.77%)
DECK : 144.94 (+1.60%)
NOW : 234.03 (unch)
MGLN : 64.54 (+1.64%)
IEX : 143.47 (+1.69%)
PTC : 91.26 (+0.30%)
AVT : 43.89 (-0.30%)
RGS : 18.33 (-0.33%)
BSFT : 54.95 (+0.09%)
FOSL : 14.70 (-3.61%)
WAL : 45.92 (+1.95%)
IVR : 15.98 (+0.25%)
ENR : 45.55 (+0.02%)
ISBC : 12.69 (+1.44%)
SHOO : 34.59 (+0.70%)
HDP : 14.68 (+1.80%)
AWK : 97.46 (+0.22%)
OMED : 0.95 (+23.38%)
LADR : 17.65 (+0.63%)
BIG : 32.43 (+0.84%)
WY : 25.50 (+0.31%)
JBLU : 18.07 (-0.06%)
GNMK : 6.29 (+3.62%)
FORM : 15.87 (+0.13%)
PFSI : 22.81 (+1.29%)
NEWM : 13.59 (+1.27%)
KFRC : 38.22 (+3.19%)
HOLX : 46.06 (+1.84%)
TMK : 83.10 (+1.55%)
AXTA : 26.53 (+0.23%)
PGEM : 21.65 (unch)
CLH : 59.95 (+0.98%)
CLI : 21.09 (+0.38%)
NRG : 42.56 (-0.12%)
CLGX : 39.68 (+0.81%)
SFLY : 46.12 (+0.48%)
ICUI : 254.20 (+1.75%)
CARA : 16.87 (+1.93%)
WTR : 35.60 (-0.14%)
NTGR : 35.59 (+0.71%)
OLED : 117.94 (+0.49%)
VNDA : 20.85 (+3.63%)
HIBB : 17.78 (+0.68%)
FFBC : 27.82 (+2.20%)
DLTR : 99.18 (+0.66%)
EQT : 18.63 (+2.36%)
OMER : 13.83 (-3.62%)
KTOS : 16.93 (-0.12%)
SRCL : 45.43 (+0.89%)
GES : 20.62 (+0.98%)
KMX : 62.17 (+1.65%)
PLAB : 11.39 (-0.26%)
NCS : 7.66 (-1.42%)
MAR : 120.46 (+1.55%)
MRVL : 18.84 (-1.82%)
UAL : 88.57 (+0.48%)
CNK : 37.01 (-0.48%)
NATH : 73.16 (+2.04%)
TPH : 13.07 (-0.08%)
OCUL : 3.68 (+0.27%)
SKYW : 55.57 (-1.03%)
HIVE : 4.40 (+1.15%)
GAIA : 11.69 (+3.18%)
ESRX : 92.33 (-3.62%)
PHM : 27.11 (+0.74%)
EBS : 65.96 (+1.46%)
CACI : 179.92 (+0.96%)
SAVE : 61.41 (-0.02%)
EZPW : 10.01 (+0.91%)
TPX : 56.57 (+0.87%)
KLAC : 107.68 (+0.50%)
ULTA : 306.87 (+0.61%)
WWE : 87.30 (-1.77%)
ESV : 4.71 (+4.90%)
LTRPA : 16.56 (-1.90%)
DAL : 51.15 (+1.33%)
BMY : 51.42 (+1.16%)
ECL : 162.79 (+0.73%)
CHRW : 91.02 (+0.35%)
WWW : 39.30 (+1.87%)
ETH : 19.64 (+0.67%)
IART : 50.79 (+0.28%)
LE : 17.57 (+2.27%)
LH : 150.34 (+2.44%)
HZO : 19.55 (+5.16%)
MTD : 666.21 (+0.50%)
OSTK : 19.67 (+2.61%)
LDOS : 63.26 (+1.49%)
SAGE : 160.79 (+1.71%)
CIEN : 39.95 (+0.60%)
MTW : 17.46 (+3.13%)
AMC : 13.87 (+1.61%)
NDLS : 7.45 (-1.46%)
EFII : 27.58 (+0.88%)
SIVB : 245.97 (+2.32%)
MU : 41.97 (-0.62%)
DSW : 27.40 (+0.04%)
VRNT : 51.90 (-0.52%)
OII : 16.54 (+2.61%)
SAFM : 120.83 (+0.31%)
DATA : 129.32 (-0.54%)
TLYS : 11.80 (-0.08%)
TREE : 316.69 (+2.50%)
TRUP : 29.34 (+6.27%)
AMCX : 64.60 (+2.47%)
EXPD : 73.54 (-0.57%)
SUPN : 39.21 (+2.54%)
NBIX : 84.50 (-0.06%)
SAIC : 76.29 (+2.31%)
CBM : 38.19 (+6.68%)
BURL : 164.03 (+1.08%)
AMED : 136.34 (-1.72%)
EXPR : 5.24 (+0.77%)
SBH : 18.72 (+0.16%)
ATSG : 24.87 (+2.90%)
PLT : 49.33 (+2.92%)
QDEL : 65.76 (+2.27%)
NLNK : 1.56 (+5.41%)
STMP : 200.69 (+1.63%)
IPCC : 142.80 (+0.32%)
BMTC : 39.71 (+2.53%)
STML : 11.45 (+3.06%)
EGL : 29.10 (+0.24%)
LUV : 57.78 (-0.38%)
CCL : 57.15 (+0.09%)
INOV : 15.08 (+6.05%)
COTY : 11.05 (-0.27%)
MGM : 28.23 (+3.14%)
AKBA : 6.45 (-0.31%)
LGIH : 60.41 (+0.68%)
CDNS : 52.30 (+1.24%)
CRZO : 12.49 (+2.55%)
TEN : 36.27 (+6.08%)
HAIN : 17.80 (+2.01%)
Consolidated Research: 2018 Summary Expectations for TD Ameritrade Holding, Supernus Pharmaceuticals, Akcea Therapeutics, Dell Technologies, iRobot, and Pegasystems -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of TD Ameritrade Holding Corporation...

AMTD : 56.61 (+2.00%)
AKCA : 27.15 (+1.00%)
SUPN : 39.21 (+2.54%)
DVMT : 80.00 (-1.39%)
IRBT : 118.19 (+2.52%)
PEGA : 57.00 (-0.31%)
DVMTV : 38.0800 (-16.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade SUPN with:

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

2nd Resistance Point 38.79
1st Resistance Point 38.51
Last Price 39.21
1st Support Level 37.79
2nd Support Level 37.35

See More

52-Week High 61.25
Fibonacci 61.8% 49.33
Fibonacci 50% 45.65
Fibonacci 38.2% 41.97
Last Price 39.21
52-Week Low 30.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar